Will Pharma Overreach in the TPPA Create A Movement for Access to Medicines? | Health and Human Rights Journal

abernard102@gmail.com 2015-10-23

Summary:

" ... Simply put, the TPPA is designed to block the sick and the poor from accessing affordable generic and biosimilar medicines. If the TPPA is ultimately approved by its member nations, it will enshrine a billions-over-millions trade-off: billions of dollars in profits will be made by patent-holding pharmaceutical corporations, and millions of people will needlessly suffer and die. But the legislative bodies of those member nations, including the US Congress, have not yet signed off on the deal. And many are facing significant pressure not to. That pressure provides an historic opportunity for advocates to not just scuttle a bad trade deal, but to elevate the human right to health. As it stands, the TPPA is a weapon of mass destruction. The final terms include multiple provisions that extend both the scope and length of patent protections. For example, the agreement guarantees market exclusivity for patented biologic drugs for at least five years in all TPPA countries, and likely eight years of de facto exclusion of more affordable versions of needed medicine.2 ..."

Link:

http://www.hhrjournal.org/2015/10/14/will-pharma-overreach-in-the-tppa-create-a-movement-for-access-to-medicines/

From feeds:

Open Access Tracking Project (OATP) ยป abernard102@gmail.com

Tags:

oa.new oa.comment oa.medicine oa.biomedicine oa.pharma oa.copyright oa.licensing oa.patents oa.tpp oa.treaties oa.advocacy oa.libre

Date tagged:

10/23/2015, 08:57

Date published:

10/23/2015, 04:57